At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Apr 26, 2026 at 20:00 ET
Insider cluster at West Pharmaceutical Services includes two small open-market sales ($1.13M total) and three non-cash director grants. The sales represent only ~0.005% of the $21.9B market cap, making them trivial and routine. This follows a strong Q1 earnings beat (filed Apr 23), suggesting no negative signal.
- Two executive sales: $860K by SVP Annette Favorite and $269K by VP Chad Winters
- Three director grants of 791 shares each at $0 (non-cash)
- Total sales value $1.13M is only ~0.005% of market cap ($21.9B)
- Cluster follows strong Q1 earnings on Apr 23: revenue +21% YoY, EPS +47% YoY
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access